Stock analysis, AI verdict, fundamentals & technical signals
Rating: NEUTRAL
Price: $19.11 Analyst target: $27.76 Upside: 45.26%
Tandem Diabetes Care, Inc., a medical device company, designs, develops, and markets various products for people with insulin-dependent diabetes in the United States. The company is headquartered in San Diego, California.
See the full interactive analysis & chart →Informational only — not investment advice.